Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.17
$0.087.34%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.20M | 24.42M | 21.29M | 36.66M | 36.66M |
| Total Depreciation and Amortization | 4.72M | 4.75M | 6.04M | 3.47M | 3.47M |
| Total Amortization of Deferred Charges | -- | -- | 596.60K | -- | -- |
| Total Other Non-Cash Items | 14.74M | 7.36M | -1.67M | 16.50M | 16.50M |
| Change in Net Operating Assets | -11.53M | -43.93M | 37.75M | -32.72M | -32.72M |
| Cash from Operations | 26.13M | -7.40M | 64.00M | 23.92M | 23.92M |
| Capital Expenditure | -4.44M | -5.19M | -8.35M | -934.30K | -934.30K |
| Sale of Property, Plant, and Equipment | 151.00K | -- | 462.00K | 195.10K | 195.10K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.02M | 1.74M | 6.36M | -3.90M | -3.90M |
| Cash from Investing | -5.30M | -3.45M | -1.53M | -4.63M | -4.63M |
| Total Debt Issued | 2.40B | 850.00M | 727.22M | 1.79B | 1.79B |
| Total Debt Repaid | -2.10B | -351.35M | -913.66M | -1.74B | -1.74B |
| Issuance of Common Stock | 36.08M | -- | 1.64B | 40.89M | 73.17M |
| Repurchase of Common Stock | -- | -55.93M | -1.66B | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | -9.57M | -9.12M | -12.08M | -12.08M |
| Other Financing Activities | -191.58M | -214.83M | -228.95M | -182.04M | -214.33M |
| Cash from Financing | 7.21M | 1.59M | -30.84M | -17.46M | -17.46M |
| Foreign Exchange rate Adjustments | -6.05M | -697.60K | 1.19M | 2.04M | 2.04M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.99M | -9.95M | 32.82M | 3.87M | 3.87M |